Drugs, Alcohol, Pregnancy, and the Child Series
Over one million children in this country per year are delivered to women who have used alcohol, tobacco, marijuana, or illicit drugs during pregnancy. This webinar series will explore the biological and environmental factors for mothers, children and families that impact the ultimate development of children affected by prenatal substance exposure and provide an overview of family- and school-based intervention strategies that can promote long-term growth and development of this high-risk population of children.
Drug Use in Pregnancy: Mother and Child
Wednesday, June 28, 2023
12:00 p.m.–1:30 p.m.
Webinar
A child’s prenatal exposure to maternal substance use during gestation is recognized as one of the most significant barriers to the child’s ultimate healthy development. The direct biological toxicity of the drugs and the social and psychological disarray of the substance-misusing environment ultimately impede the child’s growth and development and pose a grave risk to the child’s overall well-being. This session will address the neurobiological changes that occur in the pregnant woman and the developing fetus as a result of exposure to tobacco, marijuana and illicit drugs and describe maternal and neonatal outcomes in pregnancies complicated by substance misuse.
Learning objectives
At the conclusion of this session, participants will be able to:
This course is provided by Connecticut Hospital Association.
For more information please contact CHA Education Services on Phone # 203-294-7263 or by email address educationservices@chime.org.
Starts On
Registration Begins
Registration Ends